Dr. Rafael Rosell

Oncologist

Consults at:

Dexeus University Hospital

5.0

Surgeries

N/A

Experience

N/A years

Get A Consultation

About

Dr. Rosell is the Medical Director and President of the Dr. Rosell Oncology Institute (Dexeus University Hospital; Teknon Medical Centre; Sagrat Cor University Hospital, Barcelona; and Catalonia General University Hospital, Sant Cugat dels Vallés; all part of the Quirónsalud Group).

Dr. Rosell has specialised in oncology since 1982. Since then, he has worked tirelessly on researching a cure for cancer. Dr. Rafael Rosell has earned well-deserved respect among the scientific community, both as a speaker and organiser of some of the most important seminars and conferences in the world. He pays special attention to the field of translational oncology of large-cell lung cancer. As Head of the Dr. Rosell Oncology Institute, he works closely with the Oncology Laboratory to provide molecular diagnoses and personalised treatments depending on the genetic characteristics of each patient. In 2013, The Lancet named Dr. Rosell as the European leader in lung cancer.

Education

MD, PhD

Experience

Director of the Cancer Biology and Personalized Medicine Programme, Catalonian Institute of Oncology, Germans Trias i Pujol Hospital, Badalona (Barcelona).
Founder and Projects and International Relations Director of the Spanish Lung Cancer Group (GECP).

Awards

Founder and Scientific Director of Pangaea Oncology S.A.
Founder and President of the Molecular Oncology Research Foundation (MORe).
Founding Board Member of the European Thoracic Oncology Platform (ETOP).
He has given over 800 presentations at conference, as well as organizing some of the most important seminars and conferences in the world, for example, the International Association for the Study of Lung Cancer (IASLC), the European Medical Oncology Society (ESMO) and the American Society of Clinical Oncology (ASCO).
International Association for the Study of Lung Cancer (IASLC); Chair, 2005 World Conference on Lung Cancer.
European Society for Medical Oncology (ESMO); Member, Scientific Program Sub-Committee (non-small-cell lung cancer, metastatic) for the ESMO annual congress.
European Organization for Research and Treatment of Cancer (EORTC).
American Society of Clinical Oncology (ASCO); Member of Scientific Program Committee 2002-2004.
Spanish Lung Cancer Group (President, 1991-2014).